866-997-4948(US-Canada Toll Free)

China Leukemia Therapeutics Market Research Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 105 Pages

The global Leukemia Therapeutics market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Leukemia Therapeutics development status and future trend in China, focuses on top players in China, also splits Leukemia Therapeutics by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Roche
GlaxoSmithKline
Novartis
Bristol-Myers Squibb
Eisai
Biogen Idec
ERYtech Pharma
Celgene
Genmab
Cephalon
Clavis Pharma
Pfizer

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Gleevec
Sprycel
Tasigna
Clolar
Others

On the basis of the end users/application, this report covers
Hospital
Clinic

Table of Contents

China Leukemia Therapeutics Market Research Report 2018
1 Leukemia Therapeutics Overview
1.1 Product Overview and Scope of Leukemia Therapeutics
1.2 Classification of Leukemia Therapeutics by Product Category
1.2.1 China Leukemia Therapeutics Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Leukemia Therapeutics Sales (K Units) Market Share by Type in 2017
1.2.3 Gleevec
1.2.4 Sprycel
1.2.5 Tasigna
1.2.6 Clolar
1.2.7 Others
1.3 China Leukemia Therapeutics Market by Application/End Users
1.3.1 China Leukemia Therapeutics Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 China Leukemia Therapeutics Market by Region
1.4.1 China Leukemia Therapeutics Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Leukemia Therapeutics Status and Prospect (2013-2025)
1.4.3 East China Leukemia Therapeutics Status and Prospect (2013-2025)
1.4.4 Southwest China Leukemia Therapeutics Status and Prospect (2013-2025)
1.4.5 Northeast China Leukemia Therapeutics Status and Prospect (2013-2025)
1.4.6 North China Leukemia Therapeutics Status and Prospect (2013-2025)
1.4.7 Central China Leukemia Therapeutics Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Leukemia Therapeutics (2013-2025)
1.5.1 China Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 China Leukemia Therapeutics Market Competition by Players/Manufacturers
2.1 China Leukemia Therapeutics Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Leukemia Therapeutics Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Leukemia Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Leukemia Therapeutics Market Competitive Situation and Trends
2.4.1 China Leukemia Therapeutics Market Concentration Rate
2.4.2 China Leukemia Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Leukemia Therapeutics Manufacturing Base Distribution, Sales Area, Product Types

3 China Leukemia Therapeutics Sales and Revenue by Region (2013-2018)
3.1 China Leukemia Therapeutics Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Leukemia Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Leukemia Therapeutics Price (USD/Unit) by Regions (2013-2018)

4 China Leukemia Therapeutics Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Leukemia Therapeutics Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Leukemia Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Leukemia Therapeutics Price (USD/Unit) by Type (2013-2018)
4.4 China Leukemia Therapeutics Sales Growth Rate (%) by Type (2013-2018)

5 China Leukemia Therapeutics Sales by Application (2013-2018)
5.1 China Leukemia Therapeutics Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Leukemia Therapeutics Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 China Leukemia Therapeutics Players/Suppliers Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Leukemia Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Leukemia Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Leukemia Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Leukemia Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bristol-Myers Squibb Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 Eisai
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Leukemia Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eisai Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Biogen Idec
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Leukemia Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Biogen Idec Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 ERYtech Pharma
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Leukemia Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 ERYtech Pharma Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Celgene
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Leukemia Therapeutics Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celgene Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Genmab
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Leukemia Therapeutics Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Genmab Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
6.10 Cephalon
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Leukemia Therapeutics Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Cephalon Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.10.4 Main Business/Business Overview
6.11 Clavis Pharma
6.12 Pfizer

7 Leukemia Therapeutics Manufacturing Cost Analysis
7.1 Leukemia Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Leukemia Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Leukemia Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Leukemia Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 China Leukemia Therapeutics Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Leukemia Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Leukemia Therapeutics Sales (K Units) Forecast by Type (2018-2025)
11.3 China Leukemia Therapeutics Sales (K Units) Forecast by Application (2018-2025)
11.4 China Leukemia Therapeutics Sales (K Units) Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Table

List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Leukemia Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Leukemia Therapeutics Sales (K Units) by Application (2013-2025)
Figure Product Picture of Leukemia Therapeutics
Table China Leukemia Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Leukemia Therapeutics Sales Volume Market Share by Types in 2017
Figure Gleevec Product Picture
Figure Sprycel Product Picture
Figure Tasigna Product Picture
Figure Clolar Product Picture
Figure Others Product Picture
Figure China Leukemia Therapeutics Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Leukemia Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure South China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Leukemia Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Leukemia Therapeutics Sales of Key Players/Manufacturers (2013-2018)
Table China Leukemia Therapeutics Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Leukemia Therapeutics Sales Share (%) by Players/Manufacturers
Figure 2017 China Leukemia Therapeutics Sales Share (%) by Players/Manufacturers
Table China Leukemia Therapeutics Revenue by Players/Manufacturers (2013-2018)
Table China Leukemia Therapeutics Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Leukemia Therapeutics Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Leukemia Therapeutics Revenue Market Share (%) by Players/Manufacturers
Table China Market Leukemia Therapeutics Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Leukemia Therapeutics Average Price of Key Players/Manufacturers in 2017
Figure China Leukemia Therapeutics Market Share of Top 3 Players/Manufacturers
Figure China Leukemia Therapeutics Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Leukemia Therapeutics Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Leukemia Therapeutics Product Category
Table China Leukemia Therapeutics Sales (K Units) by Regions (2013-2018)
Table China Leukemia Therapeutics Sales Share (%) by Regions (2013-2018)
Figure China Leukemia Therapeutics Sales Share (%) by Regions (2013-2018)
Figure China Leukemia Therapeutics Sales Market Share (%) by Regions in 2017
Table China Leukemia Therapeutics Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Leukemia Therapeutics Revenue Market Share (%) by Regions (2013-2018)
Figure China Leukemia Therapeutics Revenue Market Share (%) by Regions (2013-2018)
Figure China Leukemia Therapeutics Revenue Market Share (%) by Regions in 2017
Table China Leukemia Therapeutics Price (USD/Unit) by Regions (2013-2018)
Table China Leukemia Therapeutics Sales (K Units) by Type (2013-2018)
Table China Leukemia Therapeutics Sales Share (%) by Type (2013-2018)
Figure China Leukemia Therapeutics Sales Share (%) by Type (2013-2018)
Figure China Leukemia Therapeutics Sales Market Share (%) by Type in 2017
Table China Leukemia Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Leukemia Therapeutics Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Leukemia Therapeutics by Type (2013-2018)
Figure Revenue Market Share of Leukemia Therapeutics by Type in 2017
Table China Leukemia Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure China Leukemia Therapeutics Sales Growth Rate (%) by Type (2013-2018)
Table China Leukemia Therapeutics Sales (K Units) by Applications (2013-2018)
Table China Leukemia Therapeutics Sales Market Share (%) by Applications (2013-2018)
Figure China Leukemia Therapeutics Sales Market Share (%) by Application (2013-2018)
Figure China Leukemia Therapeutics Sales Market Share (%) by Application in 2017
Table China Leukemia Therapeutics Sales Growth Rate (%) by Application (2013-2018)
Figure China Leukemia Therapeutics Sales Growth Rate (%) by Application (2013-2018)
Table Roche Leukemia Therapeutics Basic Information List
Table Roche Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Roche Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Roche Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Roche Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline Leukemia Therapeutics Basic Information List
Table GlaxoSmithKline Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Novartis Leukemia Therapeutics Basic Information List
Table Novartis Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novartis Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novartis Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Novartis Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Bristol-Myers Squibb Leukemia Therapeutics Basic Information List
Table Bristol-Myers Squibb Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bristol-Myers Squibb Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Bristol-Myers Squibb Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Eisai Leukemia Therapeutics Basic Information List
Table Eisai Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eisai Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eisai Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Eisai Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Biogen Idec Leukemia Therapeutics Basic Information List
Table Biogen Idec Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Biogen Idec Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Biogen Idec Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Biogen Idec Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table ERYtech Pharma Leukemia Therapeutics Basic Information List
Table ERYtech Pharma Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure ERYtech Pharma Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure ERYtech Pharma Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure ERYtech Pharma Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Celgene Leukemia Therapeutics Basic Information List
Table Celgene Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Celgene Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Celgene Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Celgene Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Genmab Leukemia Therapeutics Basic Information List
Table Genmab Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Genmab Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Genmab Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Genmab Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Cephalon Leukemia Therapeutics Basic Information List
Table Cephalon Leukemia Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Cephalon Leukemia Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Cephalon Leukemia Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Cephalon Leukemia Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Clavis Pharma Leukemia Therapeutics Basic Information List
Table Pfizer Leukemia Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Leukemia Therapeutics
Figure Manufacturing Process Analysis of Leukemia Therapeutics
Figure Leukemia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Leukemia Therapeutics Major Players/Manufacturers in 2017
Table Major Buyers of Leukemia Therapeutics
Table Distributors/Traders List
Figure China Leukemia Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Leukemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Leukemia Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table China Leukemia Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure China Leukemia Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure China Leukemia Therapeutics Sales Volume Market Share Forecast by Type in 2025
Table China Leukemia Therapeutics Sales (K Units) Forecast by Application (2018-2025)
Figure China Leukemia Therapeutics Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Leukemia Therapeutics Sales Volume Market Share Forecast by Application in 2025
Table China Leukemia Therapeutics Sales (K Units) Forecast by Regions (2018-2025)
Table China Leukemia Therapeutics Sales Volume Share Forecast by Regions (2018-2025)
Figure China Leukemia Therapeutics Sales Volume Share Forecast by Regions (2018-2025)
Figure China Leukemia Therapeutics Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *